Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$35.55 - $43.57 $223,929 - $274,447
-6,299 Reduced 66.75%
3,138 $136,000
Q3 2023

Nov 13, 2023

BUY
$39.13 - $47.24 $71,999 - $86,921
1,840 Added 24.22%
9,437 $382,000
Q2 2023

Aug 11, 2023

BUY
$43.93 - $46.76 $333,736 - $355,235
7,597 New
7,597 $342,000
Q4 2022

Feb 10, 2023

BUY
$41.91 - $50.48 $1.09 Million - $1.31 Million
26,035 Added 27.38%
121,106 $6.04 Million
Q3 2022

Nov 14, 2022

BUY
$40.9 - $50.42 $2.88 Million - $3.55 Million
70,479 Added 286.59%
95,071 $3.93 Million
Q2 2022

Aug 12, 2022

BUY
$42.98 - $49.77 $1.03 Million - $1.19 Million
23,955 Added 3760.6%
24,592 $1.16 Million
Q1 2022

May 13, 2022

BUY
$42.23 - $54.3 $26,900 - $34,589
637 New
637 $31,000
Q2 2021

Aug 13, 2021

SELL
$46.28 - $52.75 $284,483 - $324,254
-6,147 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$46.25 - $56.02 $1.6 Million - $1.94 Million
-34,618 Reduced 84.92%
6,147 $299,000
Q4 2020

Feb 12, 2021

BUY
$46.09 - $54.74 $1.88 Million - $2.23 Million
40,765 New
40,765 $2.15 Million
Q2 2020

Aug 14, 2020

SELL
$39.49 - $44.36 $253,762 - $285,057
-6,426 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$33.17 - $41.6 $583,393 - $731,660
-17,588 Reduced 73.24%
6,426 $267,000
Q4 2019

Feb 13, 2020

SELL
$25.41 - $43.1 $294,756 - $499,960
-11,600 Reduced 32.57%
24,014 $812,000
Q3 2019

Nov 08, 2019

BUY
$32.73 - $40.81 $958,727 - $1.2 Million
29,292 Added 463.33%
35,614 $1.17 Million
Q2 2019

Aug 14, 2019

SELL
$35.73 - $41.39 $1.2 Million - $1.39 Million
-33,544 Reduced 84.14%
6,322 $256,000
Q1 2019

May 15, 2019

BUY
$33.78 - $40.68 $1.35 Million - $1.62 Million
39,866 New
39,866 $1.62 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.5B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.